IRIS
SAMMARTINO, JOSE' CAMILLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.859
AS - Asia 1.472
EU - Europa 981
SA - Sud America 206
AF - Africa 76
OC - Oceania 1
Totale 4.595
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.786
CN - Cina 401
SG - Singapore 383
VN - Vietnam 233
HK - Hong Kong 226
RU - Federazione Russa 194
BR - Brasile 154
DE - Germania 151
IE - Irlanda 150
IT - Italia 125
FI - Finlandia 93
FR - Francia 81
GB - Regno Unito 57
IN - India 52
ZA - Sudafrica 47
CA - Canada 43
JP - Giappone 34
BD - Bangladesh 29
ES - Italia 25
MX - Messico 22
SE - Svezia 20
TR - Turchia 20
PL - Polonia 19
IQ - Iraq 14
NL - Olanda 14
PK - Pakistan 14
AT - Austria 13
PH - Filippine 12
VE - Venezuela 11
ID - Indonesia 10
AR - Argentina 9
EC - Ecuador 7
SA - Arabia Saudita 7
CL - Cile 6
CO - Colombia 6
CZ - Repubblica Ceca 6
TN - Tunisia 6
UZ - Uzbekistan 6
CH - Svizzera 5
LT - Lituania 5
PE - Perù 5
UA - Ucraina 5
BE - Belgio 4
KE - Kenya 4
MA - Marocco 4
MY - Malesia 4
BO - Bolivia 3
DZ - Algeria 3
EG - Egitto 3
JM - Giamaica 3
KG - Kirghizistan 3
KZ - Kazakistan 3
PT - Portogallo 3
PY - Paraguay 3
RO - Romania 3
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
KR - Corea 2
LB - Libano 2
OM - Oman 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CR - Costa Rica 1
CV - Capo Verde 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
IR - Iran 1
KW - Kuwait 1
MN - Mongolia 1
MU - Mauritius 1
MZ - Mozambico 1
NA - Namibia 1
NI - Nicaragua 1
NO - Norvegia 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TG - Togo 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 4.595
Salva come PNG Salva come JPEG
Città #
San Jose 282
Hong Kong 222
Singapore 222
Ashburn 199
Dallas 186
Dublin 142
Beijing 127
Chandler 121
New York 98
Ho Chi Minh City 86
Munich 81
Boardman 68
Helsinki 65
Los Angeles 64
Lauterbourg 53
Shanghai 51
Hanoi 50
Johannesburg 38
Moscow 32
Redondo Beach 29
Turku 28
The Dalles 27
Pavia 24
Tokyo 24
Santa Clara 23
Milan 20
Orem 20
Princeton 20
Lawrence 19
Buffalo 18
Medford 18
Warsaw 17
Frankfurt am Main 16
Toronto 16
Denver 15
Montreal 15
Seattle 15
Stockholm 15
Council Bluffs 14
São Paulo 14
Chennai 13
Wilmington 13
Chicago 12
Columbus 12
Biên Hòa 11
Brooklyn 11
Da Nang 11
Poplar 11
Rome 11
Amsterdam 10
Boston 10
Mexico City 10
Nuremberg 10
Charlotte 9
Düsseldorf 9
Haiphong 9
London 9
Washington 9
Ann Arbor 8
Lecce 8
Baghdad 7
Houston 7
Hải Dương 7
Mumbai 7
Nanjing 7
Shenyang 7
Ankara 6
Atlanta 6
Changsha 6
Falkenstein 6
Hangzhou 6
Jakarta 6
Manchester 6
Tashkent 6
Utrera 6
Belo Horizonte 5
Brasília 5
Istanbul 5
Lahore 5
New Delhi 5
Phoenix 5
San Francisco 5
Dearborn 4
Dhaka 4
Honolulu 4
Jeddah 4
Karachi 4
Medellín 4
Nanchang 4
Olomouc 4
Piscataway 4
Asunción 3
Bishkek 3
Bologna 3
Boves 3
Brussels 3
Bến Tre 3
Cairo 3
Cao Lanh 3
Cape Town 3
Totale 2.994
Salva come PNG Salva come JPEG
Nome #
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 148
19n01, a Broadly Neutralizing Antibody Against Omicron BA.1, BA.2, BA.4/5, and Other SARS-CoV-2 Variants of Concern 121
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 118
An Overview on the Potential Antimycobacterial Agents Targeting Serine/Threonine Protein Kinases from Mycobacterium tuberculosis 117
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 113
Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice 112
SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers 111
New insights into the mechanism of action of the thienopyrimidine antitubercular prodrug TP053 108
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug 107
Characterization of immune response against monkeypox virus in cohorts of infected patients, historic and newly vaccinated subjects 106
Design and Synthesis of Pyrano[3,2-b]indolones Showing Antimycobacterial Activity 106
Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents 101
Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers 100
Targeting iron uptake pathway for the development of novel antitubercular drugs. 100
First triclosan-based macrocyclic inhibitors of InhA enzyme 100
Functional investigation of the antitubercular drug target Decaprenylphosphoryl-β-D-ribofuranose-2-epimerase DprE1/DprE2 complex 98
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study 94
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study 91
Macrophages and monocytes: “trojan horses” in covid-19 90
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 90
Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment 89
Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis 88
Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients 85
Effect of different surface treatments on titanium dental implant micro-morphology 85
Immunity to SARS-CoV-2 up to 15 months after infection 84
Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients 84
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients 83
Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis 81
Comparative analysis of the chemical composition and microstructure conformation between different dental implant Bone Drills 76
Adapting Neutralizing Antibodies to Viral Variants by Structure-Guided Affinity Maturation Using Phage Display Technology 76
Shedding X-ray light on the role of magnesium in the activity of M. tuberculosis salicylate synthase (MbtI) for drug design 72
Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy 71
Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients. 71
In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates. 71
Effect of Low Copper Doping on the Optical, Cytocompatible, Antibacterial, and SARS-CoV-2 Trapping Properties of Calcium Phosphate Glasses 70
Effect of different titanium dental implant surfaces on human adipose mesenchymal stem cell behavior. An in vitro comparative study 70
Clinical Influence of Micromorphological Structure of Dental Implant Bone Drills 70
The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme 70
Annotation process, guidelines and text corpus of small non-coding RNA molecules: The MiNCor for microRNA annotations 68
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents 68
Neutralizing antibody levels against SARS-CoV-2 variants of concern Delta and Omicron in vaccine breakthrough-infected blood donors 67
Evaluation of the Neutralizing Antibodies Response against 14 SARS-CoV-2 Variants in BNT162b2 Vaccinated Naïve and COVID-19 Positive Healthcare Workers from a Northern Italian Hospital 67
Robust and persistent b-and t-cell responses after covid-19 in immunocompetent and solid organ transplant recipient patients 65
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern 65
Real-life lack of evidence of viable SARS-CoV-2 transmission via inanimate surfaces: The SURFACE study 65
Characterization of CCP: Can We Use Past Convalescent Plasma from COVID-19 Patients for Treatment of New Emerging Variants? 63
mRNA BNT162b Vaccine Elicited Higher Antibody and CD4+ T-Cell Responses than Patients with Mild COVID-19 63
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant 62
Local delivery of the hemostatic agent tranexamic acid in chronically anticoagulated patients 62
High-throughput peptide array analysis and computational techniques for serological profiling of flavivirus infections: Implications for diagnostics and vaccine development 58
P146 New weapons are necessary to fight Mycobacterium abscessus 56
Immune response to bnt162b2 in solid organ transplant recipients: Negative impact of mycophenolate and high responsiveness of sars-cov-2 recovered subjects against delta variant 54
SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment 52
Platelet-rich plasma counteracts detrimental effect of high-glucose concentrations on mesenchymal stem cells from Bichat fat pad 51
White cell and platelet content affects the release of bioactive factors in different blood-derived scaffolds 49
Genotyping of Toxoplasma gondii strain directly from human CSF samples of congenital toxoplasmosis clinical case 48
Micro-scale surface patterning of titanium dental implants by anodization in the presence of modifying salts 43
Fitness cost of rifampin resistance in Neisseria meningitidis: In Vitro study of mechanisms associated with rpoB H553Y mutation 35
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant 34
Totale 4.722
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.298
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.298
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/2022100 0 1 0 9 1 1 3 6 6 12 11 50
2022/2023448 32 40 3 29 27 24 0 16 240 13 21 3
2023/2024477 44 90 32 23 38 126 35 24 2 16 12 35
2024/20251.103 28 68 15 22 24 76 67 51 273 72 162 245
2025/20262.474 192 157 283 328 303 106 582 151 237 135 0 0
Totale 4.722